Melvina Wong-Zaza

Director Melvina Wong-Zaza bought 3,500 shares of KRNY at $8.58; holdings now 33,910 shares (+11.5%)

Melvina Wong-Zaza, a Director of Kearny Financial Corp., purchased 3,500 shares at $8.58 on 2026-06-11, increasing her holdings by +11.5% to 33,910 shares total. The stock has appreciated 10.6% in the 30 days following the transaction and currently trades at $8.73, near its 52-week high of $8.78. Her prior trading history at this ticker shows mixed timing outcomes: 3 of 5 prior buys proved well-timed (positive 90-day returns), though this includes both strong performers (90d returns of +34.5%, +7.3%, +7.2%) and significant underperformers (−12.0%, −0.9%). The company's fundamentals remain solid with net income of $10,137,000.00 and annual revenue growth of +36.0%, though latest quarterly revenue of $910,000.00 warrants context against prior periods to assess whether growth momentum is sustained.

KRNY director Melvina Wong-Zaza buys 1,375 shares at $5.93; stock down 30.0% from 52-week high, third buy in week.

Director Melvina Wong-Zaza purchased 1,375 shares of Kearny Financial Corp. at $5.93 on 2025-08-08, raising her holdings to 30,410 shares. This is the third open-market buy in eight days (prior buys on 2025-08-01), occurring as KRNY trades at $5.94—30.0% below its 52-week high and down 9.4% over the past 30 days. At the same ticker, Wong-Zaza's prior four measurable trades show mixed outcomes: two of four were well-timed at the 90-day mark, with gains ranging from -12.0% to +34.5%. The company's fundamentals are conflicted: net income of $6.6M and annual revenue growth of 36.0% sit alongside full-year negative net income and a market cap of $383.6M. The clustering of three buys within eight days, paired with the insider's 50% same-ticker success rate, neither strongly confirms conviction nor dismisses the activity as routine rebalancing.

KRNY Director Wong-Zaza buys 1,500 shares at $5.99; stock down -15.2% in 30 days, -30.5% from 52-week high

On 2025-08-01, Director Melvina Wong-Zaza purchased 1,500 shares of Kearny Financial Corp. at $5.99, increasing her holdings by 5.4% to 29,035 shares. The timing comes during significant weakness: the stock trades at $5.89, down 15.2% in the past 30 days and 30.5% from its 52-week high of $8.48. Wong-Zaza's prior purchases at KRNY show mixed timing outcomes—her 5 previous open-market buys at this ticker yielded a 40% on-target 90-day return rate, but her most recent buy on 2025-02-07 has posted -8.8% at 30 days and -12.0% at 90 days. While the company reported strong revenue growth of 36.0% year-over-year and a latest quarterly revenue of $910.0K with net income of $6.6M for that period, it was unprofitable on a full-year basis, introducing uncertainty about operational sustainability. The accumulation during a drawdown occurs against a history of mixed success—neither a clear pattern of prescient timing nor a dominant pattern of misjudgment at this specific ticker.

Director Melvina Wong-Zaza purchased 5,000 KRNY shares at $7.23 (2/7/25); holdings now 27.5K shares (+22.2% pre-transaction)

Wong-Zaza acquired 5,000 shares at $7.23 on 2025-02-07, increasing her stake by 22.2% to 27,535 shares total. At her prior five trades at KRNY, she achieved a 40% win rate on the 90-day lookback—two of five prior buys were well-timed, with 90-day returns of +34.5% (Aug 2024) and +9.2% (May 2024). Her cross-ticker track record across eight prior buys averaged -3.4% over 30 days and +1.6% over 90 days (37.50% win rate). The company reported $910.0K revenue in the latest quarter against $6.6M net income, and annual revenue growth of +36.0%, though it was unprofitable on a full-year basis. Current price $7.43 sits -12.4% from the 52-week high of $8.48 but +11.1% over 30 days, suggesting recent price stabilization after weakness.

Director Melvina Wong-Zaza purchased 1,600 shares of KRNY at $6.21 on 2024-08-15, raising holdings to 22,535 shares (+7.6%).

Wong-Zaza acquired 1,600 shares at $6.21 on 2024-08-15, extending a pattern of regular accumulation at this ticker; she has completed 5 prior trades at KRNY within 9 months. Her timing at this ticker has been mixed: of her measurable 90-day outcomes on prior buys, only 1 of 3 proved well-timed (the 2023-11-01 buy returned +11.0% over 90 days), while her 2024-02-14 purchases each declined 11.9–12.8% over 90 days. Cross-ticker, her 7 prior buys averaged -4.9% at 30 days and -6.0% at 90 days, with a 20% win rate. The stock has declined 8.6% over the past 30 days and sits 31.5% below its 52-week high of $9.37, suggesting the director is purchasing into current weakness. Fundamentally, KRNY shows strong earnings ($7.4M net income on $910.0K quarterly revenue) and 36% annual revenue growth, supporting the valuation context at $6.42 current price.

Director Wong-Zaza Melvina bought 6,000 shares of KRNY at $7.13; stock down -25.9% from 52-week high, holdings now 20,935 shares (+40.2%).

Wong-Zaza purchased 6,000 shares at $7.13 on 2024-07-31, increasing her position by 40.2% to 20,935 shares. The stock is currently trading at $6.94, down -25.9% from its 52-week high of $9.37 and -2.7% from the purchase price. Her prior trades at KRNY show mixed timing: of 5 previous buys at this ticker, only 1 (the 2023-11-01 purchase) achieved a positive 90-day return (+11.0%), while the most recent buy on 2024-05-21 showed a -6.7% 30-day return. Across her broader cross-ticker trading history, 6 prior buys averaged -4.9% at 30 days and -6.0% at 90 days with a 20% win rate, suggesting a pattern of purchases that do not consistently precede near-term gains. The company shows solid fundamentals (net income $7.4M, annual revenue growth +36.0%, P/E 28.92) but current valuation remains compressed relative to recent peaks.